Year-end report 2010

Fourth quarter, October 1 - December 31, 2010

  * Consolidated net sales amounted to SEK 949 M (1,020), a decrease of 7%
    compared with the same period in 2009.
  * Operating loss in the Group amounted to SEK 342 M (+208). Earnings were
    negatively affected by SEK 253 M in reversed deferred tax in ICA Norway and
    by a SEK 284 M impairment of goodwill in Hemtex. Excluding these items
    operating profit amounted to SEK 195 M (208).  Loss before tax was SEK 317 M
    (+242).
  *  Loss for the period amounted to SEK 330 M (+231). Earnings per share
    attributable to owners of the parent amounted to SEK -2.04 (1.46) before and
    after dilution.
  *  The ICA Group's net sales decreased by 0,4% compared with the previous
    year. Operating profit decreased to SEK 718 M (929), -22.7%.

Period January 1 - December 31, 2010

  * Consolidated net sales amounted to SEK 2,931 M (2,392), an increase of 23%
    compared with the same period in 2009. The increase is mainly due to the
    extended ownership in Hemtex.
  *  Operating loss in the Group was SEK 422 M (+423). Operating result was
    affected by a SEK 552 M relating to tax items in ICA and by a SEK 284 M
    relating to impairment of goodwill in Hemtex. Operating loss in Hemtex
    amounted to SEK 233 M. Loss before tax amounted to SEK 378 M (+671).
  *  Loss for the period amounted to SEK 391 M (+701). Earnings per share
    attributable to owners of the parent amounted to SEK -1.89 (4.52) before and
    after dilution.
  *  The ICA Group's net sales decreased by 0.8%. Operating profit rose to SEK
    2,924 M (2,713), an increase of 7.8%.

Significant events after the end of the period

  * Hakon Invest guarantees its share, 68.5%, in the forthcoming preferential
    rights issue in Hemtex. The total capital contribution amounts to
    approximately SEK 325 M.
  *  The Board of Hakon Invest proposes a dividend of SEK 6.00 per common share
    (6.00).

For further information, please contact:

CEO                                        CFO
Claes-Göran Sylvén                                        Göran Blomberg
Ph +46 8 55 33 99 64                                        Ph +46 8 55 33 99 99
cgs@hakoninvest.se
goran.blomberg@hakoninvest.se

IR
Cecilia Lannebo
Ph +46 8 55 33 99 55
cecilia.lannebo@hakoninvest.se























[HUG#1489227]